well nothing whytee said is wrong ..! the company will take years to build based on facts that past trials are not good enough for TGA or FDA and that is why they withdrawn application from TGA and they are choosing different route for FDA as well... !
Fact that other biotech on ASX don't have revenue is irrelevant response to what whyree trying to say.
the company burned $10m in last 12 month with zero sale in EU and $12m left so there is no way it can start selling device in EU which will cover the expenses without CR... so it will take years if it has potential to be sirtex but happy to be proven wrong as a shareholder... !
OSL Price at posting:
5.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)